Altimmune
ALT
ALT
120 hedge funds and large institutions have $125M invested in Altimmune in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
120
Holders Change
-12
Holders Change %
-9.09%
% of All Funds
1.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
38
Reduced
32
Closed
42
Calls
$2.04M
Puts
$997K
Net Calls
+$1.04M
Net Calls Change
-$10.6M
Top Buyers
| 1 |
1
BlackRock
New York
|
$12.9M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$11.7M |
| 3 |
3
D.E. Shaw & Co
New York
|
$1.78M |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$3.42M |
| 5 |
5
Marshall Wace
London,
United Kingdom
|
$7.27M |
Top Sellers
| 1 |
1
State Street
Boston,
Massachusetts
|
$2.84M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$1.17M |
| 3 |
LCM
3
Laurion Capital Management
New York
|
$6.49M |
| 4 |
IC
4
Ikarian Capital
Dallas,
Texas
|
$0 |
| 5 |
5
Goldman Sachs
New York
|
$611K |
